摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to a polymorphic form of 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl)benzamide (ST-246 compound), a method for producing the polymorphic form, and a pharmaceutical composition containing said polymorphic form.EFFECT: producing new compounds.13 cl, 24 dwg, 18 tbl, 11 ex |